Smart Insulin Pens Market By Type (First Generation Pens, Second Generation Pens), By Usability (Prefilled, Reusable), By End User (Hospitals and Clinics, Ambulatory Surgical Centers, Home Care Settings): Global Opportunity Analysis and Industry Forecast, 2020-2030

Smart Insulin Pens Market

Smart insulin pens are used for external insulin delivery, thus offering an easy to carry solution to diabetes management. A smart insulin pen or connected pen is an insulin pen that pairs with a mobile app. It helps to manage diabetes by improving insulin administration. These “second-generation” pens pair with USB or Bluetooth technology to enable wireless transmission of data to the app. This makes titrating insulin or making changes to regimes easier. Smart pens can streamline diabetes information across multiple platforms. For example, smart pen, app, and continuous glucose monitor or blood sugar monitor can sync information to generate data that is in one place and is easier to understand. 

Smart Insulin Pens Market trends include the increase in demand for self-injection devices, rise in prevalence of diabetes, and accuracy in dosage delivery of insulin. However, limited usage of smart insulin pens for patients requiring a mixture of two types of insulin restrict the smart insulin pens market size growth.

By type, first generation pens are expected to dominate the market throughout the analysis period. However, the second-generation pens segment is expected to register the highest CAGR of 13.6% during the forecast period, owing to rise in demand for technically advanced smart insulin pens. Second generation pens segment is expected to exhibit the fastest growth rate during the forecast period owing to increase in geriatric population and rise in the number of new product launches.

By usability, the reusable pens segment dominated the market in 2020, reusable smart insulin pens are featured with memory and timing function that provide intelligent injection for patients and this trend is expected to continue during the forecast period,. The global pre-filled smart insulin pens market was valued at $25.8 million in 2020, and is projected to reach $83.7 million by 2030, growing at a CAGR of 12.5% from 2021 to 2030. Prefilled segment is expected to exhibit the fastest growth rate during the forecast period owing to rise in awareness among people regarding the new and advanced methods for insulin delivery.

By end-user, the hospital & clinics segment dominated the market in 2020. Generally, hospitals are well equipped with diabetes management products to accommodate to the various patients with type 1 and type 2 diabetes. Hospitals and clinics have skilled professionals and staffs, which facilitate the delivery of insulin, enhance patient safety, increase patient comfort, and improve blood sugar. The global smart insulin pens market for hospital & clinics was valued at $35.5 million in 2020, and is projected to reach $107.3 million by 2030, growing at a CAGR of 11.7% from 2021 to 2030, mainly driven by the large number of patient visits to the hospitals for treatments than in clinics. Home care settings segment is expected to exhibit the fastest growth rate of CAGR 12.7% during the forecast period owing to increase in the number of home care settings that increase the demand for smart insulin pens.

By region it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Europe constitutes the largest market share for smart insulin pens market owing to the surge in demand for smart insulin pens, availability of advanced healthcare facilities with trained medical professionals, presence of key market players. It accounted for about 11.8% share of the global market in 2020 due to increasing incidence of diabetic patients. North America accounted for 12.6% share of the global smart insulin pens market. LAMEA is expected to exhibit the fastest growth rate during the forecast period due to surge in demand for smart insulin delivery products, increase in the number of advanced healthcare facilities.

The COVID-19 outbreak is anticipated to have a negative impact on the growth of the smart insulin pens market share. There is implementation of lockdown in order to control spread of COVID-19. Many hospitals are converted into COVID-19 centers hence, diabetes patients faced difficulty to get their smart insulin pens delivered on time. For instance, according to International Diabetes Federation, in 2021 approximately 537 million adults (20-79 years) had diabetes, and the total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. Furthermore, the focus of entire healthcare sector shifted toward COVID-19. Thus, COVID-19 had negative impact on smart insulin pens industry.

KEY FINDINGS OF STUDY

Based on type, the second generation pens segment is expected to grow at the highest CAGR of 13.6% during the forecast period.

Based on usability, the pre-filled pens segment is expected to grow at the highest CAGR of 12.5% during the forecast period.

Based on end users, the hospitals & clinics segment accounted for nearly half of the share of the global smart insulin pens market in 2020.

Region wise, Europe constitutes the largest market share for smart insulin pens market, registering a CAGR of 11.8% during the forecast period.

Overview

The global smart insulin pens market was valued at $94.8 million in 2020, and is estimated to reach $298.9 million by 2030, growing at a CAGR of 12.2% from 2021 to 2030.

Smart insulin pens are used for external insulin delivery thus offering an easy to carry solution for diabetes management. Different kinds of smart insulin pens and associated devices, such as smart pen caps, are in the market, and smart insulin pens with connectivity are defined as those with built-in interface technology. 

The demand for insulin pens has increased considerably in the recent years owing to surge in incidence of diabetic patients coupled with the cost-effective nature of insulin pens as compared to insulin pumps. In addition, their simple functioning and accuracy related to insulin dosing further stimulates their demand. However, there are certain disadvantages associated with the use of insulin pen such as two types of insulin cannot be mixed in an insulin pen, thus increasing the frequency of injections needed. This in turn impedes the market growth.

The smart insulin pens market is segmented on the basis of type, usability, end user, and region. By type, the market is classified into first generation and second-generation insulin pens. The second-generation insulin pens are further bifurcated into Bluetooth-enabled and USB-connected insulin pens. By usability, it is divided into pre-filled and reusable insulin pumps. According to the end user, the market is classified into hospitals & clinics, ambulatory surgical centers, and home care settings. By region, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, and Rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA).

The key players that operate in the smart insulin pens market include Berlin-Chemie, Bigfoot Biomedical, Digital Medics Pty Ltd., Eli Lilly and Company, Emperra GmbH, Jiangsu Deflu Medical Device Co. Ltd., Medtronic PLC, Novo Nordisk, Pendiq and Sanofi.

 

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the smart insulin pens market analysis from 2020 to 2030 to identify the prevailing smart insulin pens market opportunities.

The market research is offered along with information related to key drivers, restraints, and opportunities.

Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

In-depth analysis of the smart insulin pens market segmentation assists to determine the prevailing market opportunities.

Major countries in each region are mapped according to their revenue contribution to the global market.

Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

The report includes the analysis of the regional as well as global smart insulin pens market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

Eli Lilly and Compan

Scope of Smart Insulin Pens Market Report

1.1.Report description

1.2.Key market segments

1.3.Key benefits to the stakeholders

1.4.Research Methodology

1.4.1.Secondary research

1.4.2.Primary research

1.4.3.Analyst tools and models

2.1.Key findings of the study

2.2.CXO Perspective

3.1.Market definition and scope

3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis

3.4.Top player positioning

3.5.Market dynamics

3.5.1.Drivers

3.5.2.Restraints

3.5.3.Opportunities

3.6.COVID-19 Impact Analysis on the market

4.1 Overview

4.1.1 Market size and forecast

4.2 First Generation Pens

4.2.1 Key market trends, growth factors and opportunities

4.2.2 Market size and forecast, by region

4.2.3 Market analysis by country

4.3 Second Generation Pens

4.3.1 Key market trends, growth factors and opportunities

4.3.2 Market size and forecast, by region

4.3.3 Market analysis by country

5.1 Overview

5.1.1 Market size and forecast

5.2 Prefilled

5.2.1 Key market trends, growth factors and opportunities

5.2.2 Market size and forecast, by region

5.2.3 Market analysis by country

5.3 Reusable

5.3.1 Key market trends, growth factors and opportunities

5.3.2 Market size and forecast, by region

5.3.3 Market analysis by country

6.1 Overview

6.1.1 Market size and forecast

6.2 Hospitals and Clinics

6.2.1 Key market trends, growth factors and opportunities

6.2.2 Market size and forecast, by region

6.2.3 Market analysis by country

6.3 Ambulatory Surgical Centers

6.3.1 Key market trends, growth factors and opportunities

6.3.2 Market size and forecast, by region

6.3.3 Market analysis by country

6.4 Home Care Settings

6.4.1 Key market trends, growth factors and opportunities

6.4.2 Market size and forecast, by region

6.4.3 Market analysis by country

7.1 Overview

7.1.1 Market size and forecast

7.2 North America

7.2.1 Key trends and opportunities

7.2.2 North America Market size and forecast, by By Type

7.2.3 North America Market size and forecast, by Usability

7.2.4 North America Market size and forecast, by End User

7.2.5 North America Market size and forecast, by country

7.2.5.1 U.S.

7.2.5.1.1 Market size and forecast, by By Type

7.2.5.1.2 Market size and forecast, by Usability

7.2.5.1.3 Market size and forecast, by End User

7.2.5.2 Canada

7.2.5.2.1 Market size and forecast, by By Type

7.2.5.2.2 Market size and forecast, by Usability

7.2.5.2.3 Market size and forecast, by End User

7.2.5.3 Mexico

7.2.5.3.1 Market size and forecast, by By Type

7.2.5.3.2 Market size and forecast, by Usability

7.2.5.3.3 Market size and forecast, by End User

7.3 Europe

7.3.1 Key trends and opportunities

7.3.2 Europe Market size and forecast, by By Type

7.3.3 Europe Market size and forecast, by Usability

7.3.4 Europe Market size and forecast, by End User

7.3.5 Europe Market size and forecast, by country

7.3.5.1 Germany

7.3.5.1.1 Market size and forecast, by By Type

7.3.5.1.2 Market size and forecast, by Usability

7.3.5.1.3 Market size and forecast, by End User

7.3.5.2 France

7.3.5.2.1 Market size and forecast, by By Type

7.3.5.2.2 Market size and forecast, by Usability

7.3.5.2.3 Market size and forecast, by End User

7.3.5.3 U.K.

7.3.5.3.1 Market size and forecast, by By Type

7.3.5.3.2 Market size and forecast, by Usability

7.3.5.3.3 Market size and forecast, by End User

7.3.5.4 Italy

7.3.5.4.1 Market size and forecast, by By Type

7.3.5.4.2 Market size and forecast, by Usability

7.3.5.4.3 Market size and forecast, by End User

7.3.5.5 Spain

7.3.5.5.1 Market size and forecast, by By Type

7.3.5.5.2 Market size and forecast, by Usability

7.3.5.5.3 Market size and forecast, by End User

7.3.5.6 Rest of Europe

7.3.5.6.1 Market size and forecast, by By Type

7.3.5.6.2 Market size and forecast, by Usability

7.3.5.6.3 Market size and forecast, by End User

7.4 Asia-Pacific

7.4.1 Key trends and opportunities

7.4.2 Asia-Pacific Market size and forecast, by By Type

7.4.3 Asia-Pacific Market size and forecast, by Usability

7.4.4 Asia-Pacific Market size and forecast, by End User

7.4.5 Asia-Pacific Market size and forecast, by country

7.4.5.1 Japan

7.4.5.1.1 Market size and forecast, by By Type

7.4.5.1.2 Market size and forecast, by Usability

7.4.5.1.3 Market size and forecast, by End User

7.4.5.2 China

7.4.5.2.1 Market size and forecast, by By Type

7.4.5.2.2 Market size and forecast, by Usability

7.4.5.2.3 Market size and forecast, by End User

7.4.5.3 India

7.4.5.3.1 Market size and forecast, by By Type

7.4.5.3.2 Market size and forecast, by Usability

7.4.5.3.3 Market size and forecast, by End User

7.4.5.4 Australia

7.4.5.4.1 Market size and forecast, by By Type

7.4.5.4.2 Market size and forecast, by Usability

7.4.5.4.3 Market size and forecast, by End User

7.4.5.5 Rest of Asia-Pacific

7.4.5.5.1 Market size and forecast, by By Type

7.4.5.5.2 Market size and forecast, by Usability

7.4.5.5.3 Market size and forecast, by End User

7.5 LAMEA

7.5.1 Key trends and opportunities

7.5.2 LAMEA Market size and forecast, by By Type

7.5.3 LAMEA Market size and forecast, by Usability

7.5.4 LAMEA Market size and forecast, by End User

7.5.5 LAMEA Market size and forecast, by country

7.5.5.1 Brazil

7.5.5.1.1 Market size and forecast, by By Type

7.5.5.1.2 Market size and forecast, by Usability

7.5.5.1.3 Market size and forecast, by End User

7.5.5.2 Saudi Arabia

7.5.5.2.1 Market size and forecast, by By Type

7.5.5.2.2 Market size and forecast, by Usability

7.5.5.2.3 Market size and forecast, by End User

7.5.5.3 South Africa

7.5.5.3.1 Market size and forecast, by By Type

7.5.5.3.2 Market size and forecast, by Usability

7.5.5.3.3 Market size and forecast, by End User

7.5.5.4 Rest of LAMEA

7.5.5.4.1 Market size and forecast, by By Type

7.5.5.4.2 Market size and forecast, by Usability

7.5.5.4.3 Market size and forecast, by End User

8.1. Introduction

8.2. Top winning strategies

8.3. Product Mapping of Top 10 Player

8.4. Competitive Dashboard

8.5. Competitive Heatmap

8.6. Key developments

9.1 Emperra GmbH

9.1.1 Company overview

9.1.2 Company snapshot

9.1.3 Operating business segments

9.1.4 Product portfolio

9.1.5 Business performance

9.1.6 Key strategic moves and developments

9.2 Jiangsu Deflu Medical Device Co. Ltd.

9.2.1 Company overview

9.2.2 Company snapshot

9.2.3 Operating business segments

9.2.4 Product portfolio

9.2.5 Business performance

9.2.6 Key strategic moves and developments

9.3 Medtronic plc

9.3.1 Company overview

9.3.2 Company snapshot

9.3.3 Operating business segments

9.3.4 Product portfolio

9.3.5 Business performance

9.3.6 Key strategic moves and developments

9.4 Novo Nordisk

9.4.1 Company overview

9.4.2 Company snapshot

9.4.3 Operating business segments

9.4.4 Product portfolio

9.4.5 Business performance

9.4.6 Key strategic moves and developments

9.5 Pendiq

9.5.1 Company overview

9.5.2 Company snapshot

9.5.3 Operating business segments

9.5.4 Product portfolio

9.5.5 Business performance

9.5.6 Key strategic moves and developments

9.6 Sanofi

9.6.1 Company overview

9.6.2 Company snapshot

9.6.3 Operating business segments

9.6.4 Product portfolio

9.6.5 Business performance

9.6.6 Key strategic moves and developments

9.7 Berlin-Chemie

9.7.1 Company overview

9.7.2 Company snapshot

9.7.3 Operating business segments

9.7.4 Product portfolio

9.7.5 Business performance

9.7.6 Key strategic moves and developments

9.8 Bigfoot Biomedical

9.8.1 Company overview

9.8.2 Company snapshot

9.8.3 Operating business segments

9.8.4 Product portfolio

9.8.5 Business performance

9.8.6 Key strategic moves and developments

9.9 Digital Medics Pty Ltd.

9.9.1 Company overview

9.9.2 Company snapshot

9.9.3 Operating business segments

9.9.4 Product portfolio

9.9.5 Business performance

9.9.6 Key strategic moves and developments

9.10 Eli Lilly and Company

9.10.1 Company overview

9.10.2 Company snapshot

9.10.3 Operating business segments

9.10.4 Product portfolio

9.10.5 Business performance

9.10.6 Key strategic moves and development

LIST OF TABLES

TABLE 1. GLOBAL SMART INSULIN PENS MARKET, BY BY TYPE, 2020-2030,($MILLION)

TABLE 2. SMART INSULIN PENS MARKET REVENUE, FOR FIRST GENERATION PENS, BY REGION , 2020-2030,($MILLION)

TABLE 3. SMART INSULIN PENS MARKET FIRST GENERATION PENS BY COUNTRY, 2020-2030,($MILLION)

TABLE 4. SMART INSULIN PENS MARKET REVENUE, FOR SECOND GENERATION PENS, BY REGION , 2020-2030,($MILLION)

TABLE 5. SMART INSULIN PENS MARKET SECOND GENERATION PENS BY COUNTRY, 2020-2030,($MILLION)

TABLE 6. GLOBAL SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030,($MILLION)

TABLE 7. SMART INSULIN PENS MARKET REVENUE, FOR PREFILLED, BY REGION , 2020-2030,($MILLION)

TABLE 8. SMART INSULIN PENS MARKET PREFILLED BY COUNTRY, 2020-2030,($MILLION)

TABLE 9. SMART INSULIN PENS MARKET REVENUE, FOR REUSABLE, BY REGION , 2020-2030,($MILLION)

TABLE 10. SMART INSULIN PENS MARKET REUSABLE BY COUNTRY, 2020-2030,($MILLION)

TABLE 11. GLOBAL SMART INSULIN PENS MARKET, BY END USER, 2020-2030,($MILLION)

TABLE 12. SMART INSULIN PENS MARKET REVENUE, FOR HOSPITALS AND CLINICS, BY REGION , 2020-2030,($MILLION)

TABLE 13. SMART INSULIN PENS MARKET HOSPITALS AND CLINICS BY COUNTRY, 2020-2030,($MILLION)

TABLE 14. SMART INSULIN PENS MARKET REVENUE, FOR AMBULATORY SURGICAL CENTERS, BY REGION , 2020-2030,($MILLION)

TABLE 15. SMART INSULIN PENS MARKET AMBULATORY SURGICAL CENTERS BY COUNTRY, 2020-2030,($MILLION)

TABLE 16. SMART INSULIN PENS MARKET REVENUE, FOR HOME CARE SETTINGS, BY REGION , 2020-2030,($MILLION)

TABLE 17. SMART INSULIN PENS MARKET HOME CARE SETTINGS BY COUNTRY, 2020-2030,($MILLION)

TABLE 18. SMART INSULIN PENS MARKET, BY REGION, 2020-2030,($MILLION)

TABLE 19. NORTH AMERICA SMART INSULIN PENS MARKET, BY BY TYPE, 2020-2030,($MILLION)

TABLE 20. NORTH AMERICA SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030,($MILLION)

TABLE 21. NORTH AMERICA SMART INSULIN PENS MARKET, BY END USER, 2020-2030,($MILLION)

TABLE 22. NORTH AMERICA SMART INSULIN PENS MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 23. U.S. SMART INSULIN PENS MARKET BY BY TYPE 2020-2030,($MILLION)

TABLE 24. U.S. SMART INSULIN PENS MARKET BY USABILITY 2020-2030,($MILLION)

TABLE 25. U.S. SMART INSULIN PENS MARKET BY END USER 2020-2030,($MILLION)

TABLE 26. CANADA SMART INSULIN PENS MARKET BY BY TYPE 2020-2030,($MILLION)

TABLE 27. CANADA SMART INSULIN PENS MARKET BY USABILITY 2020-2030,($MILLION)

TABLE 28. CANADA SMART INSULIN PENS MARKET BY END USER 2020-2030,($MILLION)

TABLE 29. MEXICO SMART INSULIN PENS MARKET BY BY TYPE 2020-2030,($MILLION)

TABLE 30. MEXICO SMART INSULIN PENS MARKET BY USABILITY 2020-2030,($MILLION)

TABLE 31. MEXICO SMART INSULIN PENS MARKET BY END USER 2020-2030,($MILLION)

TABLE 32. EUROPE SMART INSULIN PENS MARKET, BY BY TYPE, 2020-2030,($MILLION)

TABLE 33. EUROPE SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030,($MILLION)

TABLE 34. EUROPE SMART INSULIN PENS MARKET, BY END USER, 2020-2030,($MILLION)

TABLE 35. EUROPE SMART INSULIN PENS MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 36. GERMANY SMART INSULIN PENS MARKET BY BY TYPE 2020-2030,($MILLION)

TABLE 37. GERMANY SMART INSULIN PENS MARKET BY USABILITY 2020-2030,($MILLION)

TABLE 38. GERMANY SMART INSULIN PENS MARKET BY END USER 2020-2030,($MILLION)

TABLE 39. FRANCE SMART INSULIN PENS MARKET BY BY TYPE 2020-2030,($MILLION)

TABLE 40. FRANCE SMART INSULIN PENS MARKET BY USABILITY 2020-2030,($MILLION)

TABLE 41. FRANCE SMART INSULIN PENS MARKET BY END USER 2020-2030,($MILLION)

TABLE 42. U.K. SMART INSULIN PENS MARKET BY BY TYPE 2020-2030,($MILLION)

TABLE 43. U.K. SMART INSULIN PENS MARKET BY USABILITY 2020-2030,($MILLION)

TABLE 44. U.K. SMART INSULIN PENS MARKET BY END USER 2020-2030,($MILLION)

TABLE 45. ITALY SMART INSULIN PENS MARKET BY BY TYPE 2020-2030,($MILLION)

TABLE 46. ITALY SMART INSULIN PENS MARKET BY USABILITY 2020-2030,($MILLION)

TABLE 47. ITALY SMART INSULIN PENS MARKET BY END USER 2020-2030,($MILLION)

TABLE 48. SPAIN SMART INSULIN PENS MARKET BY BY TYPE 2020-2030,($MILLION)

TABLE 49. SPAIN SMART INSULIN PENS MARKET BY USABILITY 2020-2030,($MILLION)

TABLE 50. SPAIN SMART INSULIN PENS MARKET BY END USER 2020-2030,($MILLION)

TABLE 51. REST OF EUROPE SMART INSULIN PENS MARKET BY BY TYPE 2020-2030,($MILLION)

TABLE 52. REST OF EUROPE SMART INSULIN PENS MARKET BY USABILITY 2020-2030,($MILLION)

TABLE 53. REST OF EUROPE SMART INSULIN PENS MARKET BY END USER 2020-2030,($MILLION)

TABLE 54. ASIA-PACIFIC SMART INSULIN PENS MARKET, BY BY TYPE, 2020-2030,($MILLION)

TABLE 55. ASIA-PACIFIC SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030,($MILLION)

TABLE 56. ASIA-PACIFIC SMART INSULIN PENS MARKET, BY END USER, 2020-2030,($MILLION)

TABLE 57. ASIA-PACIFIC SMART INSULIN PENS MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 58. JAPAN SMART INSULIN PENS MARKET BY BY TYPE 2020-2030,($MILLION)

TABLE 59. JAPAN SMART INSULIN PENS MARKET BY USABILITY 2020-2030,($MILLION)

TABLE 60. JAPAN SMART INSULIN PENS MARKET BY END USER 2020-2030,($MILLION)

TABLE 61. CHINA SMART INSULIN PENS MARKET BY BY TYPE 2020-2030,($MILLION)

TABLE 62. CHINA SMART INSULIN PENS MARKET BY USABILITY 2020-2030,($MILLION)

TABLE 63. CHINA SMART INSULIN PENS MARKET BY END USER 2020-2030,($MILLION)

TABLE 64. INDIA SMART INSULIN PENS MARKET BY BY TYPE 2020-2030,($MILLION)

TABLE 65. INDIA SMART INSULIN PENS MARKET BY USABILITY 2020-2030,($MILLION)

TABLE 66. INDIA SMART INSULIN PENS MARKET BY END USER 2020-2030,($MILLION)

TABLE 67. AUSTRALIA SMART INSULIN PENS MARKET BY BY TYPE 2020-2030,($MILLION)

TABLE 68. AUSTRALIA SMART INSULIN PENS MARKET BY USABILITY 2020-2030,($MILLION)

TABLE 69. AUSTRALIA SMART INSULIN PENS MARKET BY END USER 2020-2030,($MILLION)

TABLE 70. REST OF ASIA-PACIFIC SMART INSULIN PENS MARKET BY BY TYPE 2020-2030,($MILLION)

TABLE 71. REST OF ASIA-PACIFIC SMART INSULIN PENS MARKET BY USABILITY 2020-2030,($MILLION)

TABLE 72. REST OF ASIA-PACIFIC SMART INSULIN PENS MARKET BY END USER 2020-2030,($MILLION)

TABLE 73. LAMEA SMART INSULIN PENS MARKET, BY BY TYPE, 2020-2030,($MILLION)

TABLE 74. LAMEA SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030,($MILLION)

TABLE 75. LAMEA SMART INSULIN PENS MARKET, BY END USER, 2020-2030,($MILLION)

TABLE 76. LAMEA SMART INSULIN PENS MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 77. BRAZIL SMART INSULIN PENS MARKET BY BY TYPE 2020-2030,($MILLION)

TABLE 78. BRAZIL SMART INSULIN PENS MARKET BY USABILITY 2020-2030,($MILLION)

TABLE 79. BRAZIL SMART INSULIN PENS MARKET BY END USER 2020-2030,($MILLION)

TABLE 80. SAUDI ARABIA SMART INSULIN PENS MARKET BY BY TYPE 2020-2030,($MILLION)

TABLE 81. SAUDI ARABIA SMART INSULIN PENS MARKET BY USABILITY 2020-2030,($MILLION)

TABLE 82. SAUDI ARABIA SMART INSULIN PENS MARKET BY END USER 2020-2030,($MILLION)

TABLE 83. SOUTH AFRICA SMART INSULIN PENS MARKET BY BY TYPE 2020-2030,($MILLION)

TABLE 84. SOUTH AFRICA SMART INSULIN PENS MARKET BY USABILITY 2020-2030,($MILLION)

TABLE 85. SOUTH AFRICA SMART INSULIN PENS MARKET BY END USER 2020-2030,($MILLION)

TABLE 86. REST OF LAMEA SMART INSULIN PENS MARKET BY BY TYPE 2020-2030,($MILLION)

TABLE 87. REST OF LAMEA SMART INSULIN PENS MARKET BY USABILITY 2020-2030,($MILLION)

TABLE 88. REST OF LAMEA SMART INSULIN PENS MARKET BY END USER 2020-2030,($MILLION)

TABLE 89.EMPERRA GMBH: COMPANY SNAPSHOT

TABLE 90.EMPERRA GMBH: OPERATING SEGMENTS

TABLE 91.EMPERRA GMBH: PRODUCT PORTFOLIO

TABLE 92.EMPERRA GMBH: NET SALES,

TABLE 93.EMPERRA GMBH: KEY STRATERGIES

TABLE 94.JIANGSU DEFLU MEDICAL DEVICE CO. LTD.: COMPANY SNAPSHOT

TABLE 95.JIANGSU DEFLU MEDICAL DEVICE CO. LTD.: OPERATING SEGMENTS

TABLE 96.JIANGSU DEFLU MEDICAL DEVICE CO. LTD.: PRODUCT PORTFOLIO

TABLE 97.JIANGSU DEFLU MEDICAL DEVICE CO. LTD.: NET SALES,

TABLE 98.JIANGSU DEFLU MEDICAL DEVICE CO. LTD.: KEY STRATERGIES

TABLE 99.MEDTRONIC PLC: COMPANY SNAPSHOT

TABLE 100.MEDTRONIC PLC: OPERATING SEGMENTS

TABLE 101.MEDTRONIC PLC: PRODUCT PORTFOLIO

TABLE 102.MEDTRONIC PLC: NET SALES,

TABLE 103.MEDTRONIC PLC: KEY STRATERGIES

TABLE 104.NOVO NORDISK: COMPANY SNAPSHOT

TABLE 105.NOVO NORDISK: OPERATING SEGMENTS

TABLE 106.NOVO NORDISK: PRODUCT PORTFOLIO

TABLE 107.NOVO NORDISK: NET SALES,

TABLE 108.NOVO NORDISK: KEY STRATERGIES

TABLE 109.PENDIQ: COMPANY SNAPSHOT

TABLE 110.PENDIQ: OPERATING SEGMENTS

TABLE 111.PENDIQ: PRODUCT PORTFOLIO

TABLE 112.PENDIQ: NET SALES,

TABLE 113.PENDIQ: KEY STRATERGIES

TABLE 114.SANOFI: COMPANY SNAPSHOT

TABLE 115.SANOFI: OPERATING SEGMENTS

TABLE 116.SANOFI: PRODUCT PORTFOLIO

TABLE 117.SANOFI: NET SALES,

TABLE 118.SANOFI: KEY STRATERGIES

TABLE 119.BERLIN-CHEMIE: COMPANY SNAPSHOT

TABLE 120.BERLIN-CHEMIE: OPERATING SEGMENTS

TABLE 121.BERLIN-CHEMIE: PRODUCT PORTFOLIO

TABLE 122.BERLIN-CHEMIE: NET SALES,

TABLE 123.BERLIN-CHEMIE: KEY STRATERGIES

TABLE 124.BIGFOOT BIOMEDICAL: COMPANY SNAPSHOT

TABLE 125.BIGFOOT BIOMEDICAL: OPERATING SEGMENTS

TABLE 126.BIGFOOT BIOMEDICAL: PRODUCT PORTFOLIO

TABLE 127.BIGFOOT BIOMEDICAL: NET SALES,

TABLE 128.BIGFOOT BIOMEDICAL: KEY STRATERGIES

TABLE 129.DIGITAL MEDICS PTY LTD.: COMPANY SNAPSHOT

TABLE 130.DIGITAL MEDICS PTY LTD.: OPERATING SEGMENTS

TABLE 131.DIGITAL MEDICS PTY LTD.: PRODUCT PORTFOLIO

TABLE 132.DIGITAL MEDICS PTY LTD.: NET SALES,

TABLE 133.DIGITAL MEDICS PTY LTD.: KEY STRATERGIES

TABLE 134.ELI LILLY AND COMPANY: COMPANY SNAPSHOT

TABLE 135.ELI LILLY AND COMPANY: OPERATING SEGMENTS

TABLE 136.ELI LILLY AND COMPANY: PRODUCT PORTFOLIO

TABLE 137.ELI LILLY AND COMPANY: NET SALES,

TABLE 138.ELI LILLY AND COMPANY: KEY STRATERGIES LIST OF FIGURES

FIGURE 1.SMART INSULIN PENS MARKET SEGMENTATION

FIGURE 2.SMART INSULIN PENS MARKET,2020-2030

FIGURE 3.SMART INSULIN PENS MARKET,2020-2030

FIGURE 4. TOP INVESTMENT POCKETS, BY REGION

FIGURE 5.PORTER FIVE-1

FIGURE 6.PORTER FIVE-2

FIGURE 7.PORTER FIVE-3

FIGURE 8.PORTER FIVE-4

FIGURE 9.PORTER FIVE-5

FIGURE 10.TOP PLAYER POSITIONING

FIGURE 11.SMART INSULIN PENS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES

FIGURE 12.SMART INSULIN PENS MARKET,BY BY TYPE,2020(%)

FIGURE 13.COMPARATIVE SHARE ANALYSIS OF FIRST GENERATION PENS SMART INSULIN PENS MARKET,2020-2030(%)

FIGURE 14.COMPARATIVE SHARE ANALYSIS OF SECOND GENERATION PENS SMART INSULIN PENS MARKET,2020-2030(%)

FIGURE 15.SMART INSULIN PENS MARKET,BY USABILITY,2020(%)

FIGURE 16.COMPARATIVE SHARE ANALYSIS OF PREFILLED SMART INSULIN PENS MARKET,2020-2030(%)

FIGURE 17.COMPARATIVE SHARE ANALYSIS OF REUSABLE SMART INSULIN PENS MARKET,2020-2030(%)

FIGURE 18.SMART INSULIN PENS MARKET,BY END USER,2020(%)

FIGURE 19.COMPARATIVE SHARE ANALYSIS OF HOSPITALS AND CLINICS SMART INSULIN PENS MARKET,2020-2030(%)

FIGURE 20.COMPARATIVE SHARE ANALYSIS OF AMBULATORY SURGICAL CENTERS SMART INSULIN PENS MARKET,2020-2030(%)

FIGURE 21.COMPARATIVE SHARE ANALYSIS OF HOME CARE SETTINGS SMART INSULIN PENS MARKET,2020-2030(%)

FIGURE 22.SMART INSULIN PENS MARKET BY REGION,2020

FIGURE 23.U.S. SMART INSULIN PENS MARKET,2020-2030($MILLION)

FIGURE 24.CANADA SMART INSULIN PENS MARKET,2020-2030($MILLION)

FIGURE 25.MEXICO SMART INSULIN PENS MARKET,2020-2030($MILLION)

FIGURE 26.GERMANY SMART INSULIN PENS MARKET,2020-2030($MILLION)

FIGURE 27.FRANCE SMART INSULIN PENS MARKET,2020-2030($MILLION)

FIGURE 28.U.K. SMART INSULIN PENS MARKET,2020-2030($MILLION)

FIGURE 29.ITALY SMART INSULIN PENS MARKET,2020-2030($MILLION)

FIGURE 30.SPAIN SMART INSULIN PENS MARKET,2020-2030($MILLION)

FIGURE 31.REST OF EUROPE SMART INSULIN PENS MARKET,2020-2030($MILLION)

FIGURE 32.JAPAN SMART INSULIN PENS MARKET,2020-2030($MILLION)

FIGURE 33.CHINA SMART INSULIN PENS MARKET,2020-2030($MILLION)

FIGURE 34.INDIA SMART INSULIN PENS MARKET,2020-2030($MILLION)

FIGURE 35.AUSTRALIA SMART INSULIN PENS MARKET,2020-2030($MILLION)

FIGURE 36.REST OF ASIA-PACIFIC SMART INSULIN PENS MARKET,2020-2030($MILLION)

FIGURE 37.BRAZIL SMART INSULIN PENS MARKET,2020-2030($MILLION)

FIGURE 38.SAUDI ARABIA SMART INSULIN PENS MARKET,2020-2030($MILLION)

FIGURE 39.SOUTH AFRICA SMART INSULIN PENS MARKET,2020-2030($MILLION)

FIGURE 40.REST OF LAMEA SMART INSULIN PENS MARKET,2020-2030($MILLION)

FIGURE 41. TOP WINNING STRATEGIES, BY YEAR

FIGURE 42. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 43. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 44.PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 45.COMPETITIVE DASHBOARD

FIGURE 46.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS

FIGURE 47.EMPERRA GMBH.: NET SALES ,($MILLION)

FIGURE 48.JIANGSU DEFLU MEDICAL DEVICE CO. LTD..: NET SALES ,($MILLION)

FIGURE 49.MEDTRONIC PLC.: NET SALES ,($MILLION)

FIGURE 50.NOVO NORDISK.: NET SALES ,($MILLION)

FIGURE 51.PENDIQ.: NET SALES ,($MILLION)

FIGURE 52.SANOFI.: NET SALES ,($MILLION)

FIGURE 53.BERLIN-CHEMIE.: NET SALES ,($MILLION)

FIGURE 54.BIGFOOT BIOMEDICAL.: NET SALES ,($MILLION)

FIGURE 55.DIGITAL MEDICS PTY LTD..: NET SALES ,($MILLION)

FIGURE 56.ELI LILLY AND COMPANY.: NET SALES ,($MILLION